The World Health Organization maintained a low
global risk assessment on May 14, 2026, regarding a cluster of Andes virus infections aboard a Dutch-flagged cruise ship. While the risk to the general population remains low, the WHO classifies the risk for passengers and crew on the vessel as moderate
.
Andes Virus Cluster Aboard Dutch-Flagged Vessel
The World Health Organization (WHO) is monitoring a cluster of severe respiratory illnesses linked to a Dutch-flagged cruise ship. The situation first came to light on May 2, 2026, when the National IHR Focal Point of the United Kingdom of Great Britain and Northern Ireland notified the WHO of a cluster of severe acute respiratory illness. The initial reports included two deaths and one critically ill passenger.
As of May 8, 2026, the WHO reported a total of eight cases associated with the event. This figure includes six laboratory-confirmed cases and two probable cases. All six confirmed infections were identified as the Andes virus (ANDV), a specific strain of hantavirus. The virus was identified through virus-specific polymerase chain reaction (PCR) or sequencing.
The scale of the potential exposure is concentrated. According to the ship operator, 147 passengers and crew were onboard during the event, while 34 passengers and crew had previously disembarked. The closed environment of a cruise ship creates specific challenges for containment, though the WHO continues to track the movement of those exposed.
WHO Risk Stratification and Global Impact
The WHO has applied a bifurcated risk assessment to the outbreak. For the general global population, the risk is assessed as low
. This suggests that the WHO does not currently view the Andes virus as having the capacity for widespread community transmission outside the immediate cluster of the cruise ship’s passengers and crew.
Conversely, the risk for those physically present on the ship is classified as moderate
. This distinction reflects the higher probability of exposure for individuals in the immediate vicinity of the infected patients. The WHO updated this assessment on May 14, 2026, confirming that the risk levels remain unchanged despite the progression of the voyage.
Coordination of the response is being managed through the International Health Regulations (2005) (IHR) channel. National IHR Focal Points (NFPs) have been informed to support international contact tracing, ensuring that disembarked passengers are monitored for symptoms of severe respiratory illness.
Clinical Severity and Case Fatality Rates
The Andes virus is noted for its high virulence and severe clinical presentation. In this specific cluster, the WHO reported three deaths among the eight cases. This results in a case fatality ratio of 38%.
The clinical progression in these cases was characterized by severe acute respiratory illness. The use of PCR and sequencing was critical in distinguishing ANDV from other respiratory pathogens, which often present with similar symptoms during the early stages of infection. The high fatality rate underscores the danger posed to the individuals onboard, even while the global risk remains minimal.
International Coordination and Monitoring
The involvement of multiple jurisdictions—including the United Kingdom and the Netherlands (via the ship’s flag)—highlights the complexity of maritime health emergencies. Contact tracing is the primary tool currently employed to prevent the virus from establishing a foothold in any single port of call.
The WHO will continue to monitor the epidemiological situation. The focus remains on the 147 people onboard and the 34 who disembarked, as the window for symptom onset closes. Because the Andes virus can cause rapid respiratory failure, the speed of detection via PCR is the most critical factor in managing the remaining suspected or probable cases.
Consult your healthcare provider for more information on hantavirus symptoms or prevention.
